Derma Sciences (DSCI) Misses Q3 EPS by 2c

Derma Sciences (NASDAQ: DSCI) reported Q3 EPS of ($0.45), $0.02 worse than the analyst estimate of ($0.43). Revenue for the quarter came in at $20.2 million versus the consensus estimate of $21.9 million.

For earnings history and earnings-related data on Derma Sciences (DSCI) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)